SlideShare a Scribd company logo
EpiTect Methyl II PCR Array System

Samuel J. Rulli, Jr., Ph. D.
Epigenetics Applications Scientist
Samuel.Rulli@QIAGEN.com
QIAwebinars@QIAGEN.com
The EpiTect Methyl qPCR Arrays and Assays are intended for molecular biology applications.
This product is not intended for diagnosis, prevention, or treatment of disease.
1
Sample & Assay Technologies
EpiTect Methyl II PCR Array System

Questions, Comments, Concerns?
US Applications Support
888-503-3187
support@sabiosciences.com
̣

Questions, Comments, Concerns?
Global Applications Support
SAB.EU@qiagen.com

The EpiTect Methyl II PCR Arrays and Assays are intended for molecular biology applications.
This product is not intended for diagnosis, prevention, or treatment of disease.
2
Sample & Assay Technologies
Disclaimer and intended use
EpiTect Methyl II PCR Array product line

EpiTect® Kits are intended for molecular biology
applications. These products are not intended
for the diagnosis, prevention, or treatment of a
disease.

The EpiTect Methyl II qPCR system enables
pathway or disease-focused profiling of regional
DNA methylation using MethylScreen™
technology provided under license from Orion
Genomics, LLC.

For up-to-date licensing information and productspecific disclaimers, see the respective QIAGEN
kit handbook or user manual. QIAGEN kit
handbooks and user manuals are available at
www.qiagen.com or can be requested from
QIAGEN Technical Services or your local
distributor.
̣

3
Sample & Assay Technologies
Topics for Discussion
Introduction
DNA Methylation Overview
Challenges & Solutions

The EpiTect Methyl II PCR Array System
Principle and Protocol

Research Applications
Pyrosequencing
Summary

4
Sample & Assay Technologies
Basic Gene Expression Model

Protein “A”

mRNA ”A”

Structural Gene “A”

5
Sample & Assay Technologies
The Current Model
Activated
Transcription Factors

RNAi:
shRNA
miRNA

Protein “A”
NFκB

+

p53

Transcription
Initiation Complex

mRNA ”A”

–
Histones
p53 BS Me

Me

Me

Me Me

NFκB BS

DNA Methylation

Histone-DNA
Interactions

Ac

Me

Me Me

Structural Gene “A”
or Reporter system

DNA Methylation

6
Sample & Assay Technologies
The Current Model
Activated
Transcription Factors

RNAi:
shRNA
miRNA

Protein “A”
NFκB

+

p53

Transcription
Initiation Complex

mRNA ”A”

–
Histones
p53 BS Me

Me

Me

Me Me

NFκB BS

DNA Methylation

Histone-DNA
Interactions

Ac

Me

Me Me

Structural Gene “A”
TSS (+1) or Reporter system

DNA Methylation

7
Sample & Assay Technologies
DNA Methylation: Introduction
NH2
N
O
N

H NH2
H
+DNMT
O
CH3
N S-Enz
AdoMet AdoHcy R
N

NH2
-DNMT

N
CH3

O
N

5-methyl-cytosine

cytosine

Stable, covalent DNA modification that
targets CpG dinucleotides
70%-80% of the CpG dinucleotides are
methylated in healthy mammalian cells
These methylated regions are typical of
the bulk chromatin that is relatively
inaccessible to transcription factors.
Associated with gene silencing

1

Normal

2

3

Expression

Promoter
Region

Cancer
Adapted from Herman,
J. and Baylin, S. N.
Engl. J. Med. 2003

1

2

3

No
Expression

CpG islands: CpG-rich regions in
human gene promoters
Promoter CpG islands are usually
unmethylated in normal tissues.
Exceptions include genes involved in
X-chromosome inactivation, gene
imprinting and tissue-specific
expression.

8
Sample & Assay Technologies
DNA Methylation and Transcriptional Repression

9

Blood, 93:4059-4070, 1999

Sample & Assay Technologies
Critical Biological Roles for DNA Methylation
Roles in normal development and disease progression
Potentially silences expression of critical tumor suppressors
Involves all cellular pathways
Methylated DNA can be detected in heterogenous fluids
Breast cancer: nipple aspirate
Lung cancer: bronchoalveolar lavage
Prostate cancer: urine
Multiple cancers: plasma and serum

DNA Methylation: Promising Biomarker
Early detection
Predicting prognosis
Mechanism of Action for Therapy Resistance/ Therapy Choice

10
Sample & Assay Technologies
Challenges in Existing Technologies
Current Workflow for DNA Methylation Analysis:
Commonly used pretreatment – sodium bisulfite conversion
Methods of analysis – Pyrosequencing, Methylation-specific PCR (MSP),
bisulfite sequencing, next-generation sequencing, MALDI-TOF MS, etc.
Benefits – Single-base resolution of methylome
Drawbacks – Protocol Optimization, laborious for many samples, need
for specialized equipment

WHY EpiTect Methyl II qPCR System?
Available for any laboratory with qPCR instrument
Complete System- Sample Isolation to DATA Analysis
Regional Methylation Pattern
More Biology - Less Time
Complimentary to Bisulfite Based Methods
11
Sample & Assay Technologies
Site Specific DNA Methylation Analysis
Using Bisulfite Treatment
m

G T C AG T G A CG

G T C AG T G A CG

Bisulfite Conversion

Bisulfite Conversion

G T U AG T G A CG

G T U AG T G A UG

PCR

G T T AG T G A CG

PCR

G T T AG T G A T G

12
Sample & Assay Technologies
Challenges in Existing Technologies
Current Workflow for DNA Methylation Analysis:
Commonly used pretreatment – sodium bisulfite conversion
Methods of analysis – Pyrosequencing, Methylation-specific PCR (MSP),
bisulfite sequencing, next-generation sequencing, MALDI-TOF MS, etc.
Benefits – Single-base resolution of methylome
Drawbacks – Protocol Optimization, laborious for many samples, need
for specialized equipment

WHY EpiTect Methyl II qPCR System?
Available for any laboratory with qPCR instrument
Complete System- Sample Isolation to DATA Analysis
Regional Methylation Pattern
More Biology - Less Time
Complimentary to Bisulfite Based Methods
13
Sample & Assay Technologies
Topics for Discussion
Introduction
DNA Methylation Overview
Challenges & Solutions

The EpiTect Methyl II PCR Array System
Principle and Protocol

Research Applications
Pyrosequencing
Summary

14
Sample & Assay Technologies
EpiTect DNA Methylation PCR System
Complete Solution from Sample Isolation through Data Analysis
DNA Isolation: QIAGEN Blood and Tissue Kit
EpiTect Methyl II DNA Restriction Kit
For fresh/frozen tissues and cells

EpiTect Methyl II PCR Arrays
96 or 384 well format compatible with most qPCR instruments
Cataloged - multiple assays (24 or 96) on one PCR Plate
Custom - available for every promoter in the human, mouse, and rat genome

EpiTect Methyl II PCR Assays
Primers for every promoter in the human, mouse, or rat genome with CpG island
EpiTect qPCR primer assay search portal

Optimized RT2 SYBR Green Master Mix
EpiTect Methyl II Data Analysis (Excel template)
15
Sample & Assay Technologies
DNA Methylation PCR Array Protocol Overview
(0.5 – 4 ug of
Genomic DNA)

16
Sample & Assay Technologies
DNA Methylation PCR Array Protocol Overview

Sample Preparation:
QIAGEN DNeasy Blood and Tissue Kit

17
Sample & Assay Technologies
DNA Methylation PCR Array Protocol Overview
(0.5 – 4 ug of
Genomic DNA)

18
Sample & Assay Technologies
How It Works:
Principle behind EpiTect Methyl II PCR Array
Based on the quantitative detection of remaining target DNA molecules
after treatment with a Methylation-sensitive (MSRE) and a Methylationdependent (MDRE) restriction enzyme mixtures.

Enzyme

How It Works

Remaining DNA

MOCK

No enzyme added

Input fraction

MSRE

Digests unmethylated and partially
methylated DNA copies

Methylated fraction

MDRE

Digests methylated and partially
methylated DNA copies

Unmethylated fraction

MSRE & MDRE
(Double)

Digests unmethylated, partially
methylated, and methylated DNA copies

Fraction resistant to enzyme digestion
(Analytical window)

19
Sample & Assay Technologies
DNA Methylation PCR Array Protocol Overview
(0.5 – 4 ug of
Genomic DNA)

20
Sample & Assay Technologies
DNA Methylation PCR Array Protocol Overview
(0.5 – 4 ug of
Genomic DNA)

Which EpiTect Methyl II
PCR Array do I use?

21
Sample & Assay Technologies
“Catalogued” EpiTect Methyl II PCR Arrays
Simultaneously analyze the DNA methylation status of 22- or 94-gene panels associated with
specific cancer types, other diseases or biological pathways.
96 and 384 well qPCR Arrays-Human and Mouse
Cancer Related

Pathway-Focused Methyl qPCR Arrays

Breast Cancer

Apoptosis

Epithelial to Mesenchymal
Transition

DNA Repair

Gastric Cancer

Inflammatory Response

Liver Cancer

T Cell Activation

Lung Cancer

Cytokine Production

Prostate Cancer

Tumor Suppressor Genes

Colon Cancer

Homeobox (HOX) Genes

Leukemia & Lymphoma

Polycomb (PcG) Genes

Tumor Suppressor Genes

Cell Cycle

Melanoma

Toll-Like Receptor Signaling

Cancer miRNAs

Stem Cell Transcription Factors

TGF-Beta/BMP Signaling
Wnt Signaling

Custom Arrays and Custom Assays Are Available
Available for most CpG island-containing promoter in the human, mouse, or rat genome.
22

http://www.sabiosciences.com/dna_methylation_custom_PCRarray.php
Sample & Assay Technologies
DNA Methylation PCR Array Protocol Overview
(0.5 – 4 ug of
Genomic DNA)

Data
Analysis

23
Sample & Assay Technologies
EpiTect Data Analysis
Excel Analysis Templates
Quickly Understand the Biology:
Results automatically calculated, analyzed,
and annotated
No Software to download, license or
install:
Simply paste in your raw Ct values

24
Sample & Assay Technologies
Advantages of the EpiTect Methyl II PCR System
Single Gene, Pathway or Disease-Focused Analysis
Screen large number of samples for few genes with single
assays
Simultaneously detect the methylation status of 22-94 genes
Compliments & validates genome-wide methylation studies
Fast, Reliable & Sensitive
Direct measurement of methylated & unmethylated DNA
Similar results and sensitivity as bisulfite sequencing, with no
bisulfite conversion
Higher throughput than bisulfite-PCR
Highly reproducible
Genome-Wide Coverage
Primers detecting methylation status of any human, mouse, or
rat gene with predicted CpG island
Bench-validated qPCR primers
25
Sample & Assay Technologies
EpiTect Methyl II PCR Array Principle:
Representational design

Unmethylated

Unmethylated

Hypermethylated

qPCR results

Four selective methylation-specific digestion restriction

26
Sample & Assay Technologies
EpiTect Methyl II PCR Array Principle:
Representational design

Sample 1

Sample 2

Unmethylated
1

Unmethylated

Hypermethylated

methylated
1

qPCR results

Each CpG Island is interrogated at multiple sites for both RE Digests
Unbiased qPCR since both primers are the same (valid ∆Ct calculations)
Internal Standard for each Assay (mock digest versus total digest)
Representational Design

Four selective methylation-specific digestion restriction

27
Sample & Assay Technologies
EpiTect Methyl II PCR Assays
Targets
Primers available for approximately 13,000 promoter CpG islands
Design includes CpG island or CpG dense areas associated with a transcription
start site (TSS)
CpG island & TSS definitions: UCSC Genome Bioinformatics Site & NCBI
Each assay corresponds to one distinct CpG island in a promoter region
EpiTect Methyl qPCR Assay Search Portal:
http://www.sabiosciences.com/dna_methylation_qPCRprimer.php

Amplicon Specifics
Selected from 5 kb upstream to 3 kb downstream of TSS
Each includes at least three or more of both MSRE and MDRE restriction sites
Size: 150 to 400 bp (240 bp average)
28
Sample & Assay Technologies
Laboratory QC Validation
of ALL EpiTect Methyl II PCR Assays & Arrays
All EpiTect Methyl II PCR Arrays and Assays are laboratory validated:
Assays in each PCR Array are tested for
Sensitivity:
Constant C(t) value for same amount of template
Amplification Efficiency:
Single curve analysis and standard curve dilutions
Specificity:
Single melt-peak during dissociation
Validation is done on every lot of primers and every EpiTect Methyl II PCR Array
Performance of all EpiTect Methyl II PCR Assays is guaranteed when used with
the RT2 SYBR-Green qPCR Mastermix
29
Sample & Assay Technologies
EpiTect Methyl qPCR Assay Efficiency
Amplification Efficiency

Amplification and Dissociation Curves

140%

PCR Efficiency

120%
100%
80%
60%

Mouse

40%

Human

20%
0%
0

100

200

300

400

500

Amplicon length in bp

Unique qPCR cycling Conditions (critical for assay performance)
Validated Primer Specificity & High Amplification Efficiency
Similar Amplification Efficiencies for Each Primer Pair

30
Sample & Assay Technologies
Melting Curve Analysis
Single Dissociation Peaks for Every Gene Assay

Example of QC criteria for
every PCR Assay
manufactured by
SABiosciences
Single peak dissociation
curves
Single gel bands of
predicted size

31
Sample & Assay Technologies
Melting Curve Analysis
Single Dissociation Peaks for Every Gene Assay

Example of QC criteria for
every PCR Assay
manufactured by
SABiosciences
Single peak dissociation
curves
Single gel bands of
predicted size

32
Sample & Assay Technologies
Melting Curve Analysis
Single Dissociation Peaks for Every Gene Assay

Example of QC criteria for
every PCR Assay
manufactured by
SABiosciences
Single peak dissociation
curves
Single gel bands of
predicted size

33
Sample & Assay Technologies
EpiTect Methyl II PCR Arrays
Comparable to Bisulfite Sequencing
CDH13

MCF7

MB231

HeLa

Unmethylated CpG sites
Methylated CpG sites

EpiTect Methyl II PCR Assays generated quantitative
methylation data comparable to bisulfite sequencing data.
34
Sample & Assay Technologies
EpiTect Methyl qPCR Assay Sensitivity

PERCENTAGE OF TOTAL INPUT DNA

SENSITIVITY COMPARABLE TO BISULFITE SEQUENCING
100.00%
90.00%
80.00%
70.00%
60.00%
50.00%

Unmethylated

40.00%

Methylated

30.00%
20.00%
10.00%
0.00%
100.0

75.0
50.0
33.3
12.5
6.3
PERCENT SKBR3 GENOMIC DNA (%)

0.0

Methylated tumor DNA detectable in heterogeneous samples containing
as little as 5% tumor.

35
Sample & Assay Technologies
EpiTect Methyl II PCR Arrays
Comparable to Illumina Infinium BeadChip

Comparison between 94 CpG sites (22 shown) important for breast cancers in MCF-7 cells
Similar results between 2 different platforms using different preparation methods
Methyl II PCR assays can be used to validate results from large scale screening projects
36
Sample & Assay Technologies
Topics for Discussion
Introduction
DNA Methylation Overview
Challenges & Solutions

The EpiTect Methyl II PCR Array System
Principle and Protocol

Research Applications
Pyrosequencing
Summary

37
Sample & Assay Technologies
Research Applications:
Methylation in Breast Cancer
Is there a difference in the Methylation status of breast cancer associated genes
among commonly used Breast Cancer Cell lines?

Obtained genomic DNA from Human Breast Cancer Cell lines (ATCC)
Normal Breast Tissue (Capital Bioscience)

EpiTect Methyl II Breast Cancer PCR Array

38
Sample & Assay Technologies
Human Breast Cancer EpiTect Methyl II Complete
PCR Array: Functional gene groupings
Cell Cycle, Growth, Differentiation & Development: APC, ATM, BIRC5, BRCA1, BRCA2, CCNA1, CCND2, CDKN1B, CDKN1C, CDKN2A, CDKN2B, CHFR, GADD45A, GPC3, HOXD11, MEN1, PALB2,
RASSF1, SFN (14-3- 3 sigma), TERT, TGFB2, TGFBI, TGFBR1, TP73, TWIST1, VHL, WIF1, WT1, WWOX.
Transcription Factors: APC, BRCA1, BRCA2, MYOD1, CDKN2A, CDX2, HIC1, HOXA5, HOXD11, ID4, MSX1, PAX5, PLAGL1, PRDM2, PROX1, RB1, RUNX3, TP73, TWIST1, VHL, WT1, ZMYND10.
DNA Damage Repair: APC, BRCA1, BRCA2, GADD45A, MLH1, RASSF1, TERT, VHL, WWOX.
Apoptosis & Anti-Apoptosis: APC, BIRC5, BRCA1, BRCA2, DAPK1, MEN1, PYCARD, TNFRSF10C, TNFRSF10D, TP73, VHL, WWOX.
Cell Adhesion: APC, CDH1, CDH13, CADM1, CLSTN1, DSC3, EPCAM, JUP, THBS1.
Growth Factors: BMP6, IGFBP7, IGFBPL1, WIF1.
Chemokine & Cytokine Signaling: CXCL12, TNFRSF10C, TNFRSF10D.
Circadian Rhythm: PER1, PER2.
Solute Carrier Family: SLC5A8.
Drug Metabolism: CYP1B1, GSTP1.
Fatty Acid Metabolism: HSD17B4.
Heparan Sulfate Biosynthetic Enzymes: HS3ST2, HS3ST3B1.
Extracellular Matrix: LOX, MUC2, SLIT2, SLIT3, TGFBI, THBS1, TIMP3, WIF1.
Protein Kinase & Protein Kinase Adaptor Proteins: PRKCDBP.
Phosphatases: PTEN.
Prostaglandin-Endoperoxide Synthase: PTGS2.
DNA Methylation: MEN1, MGMT, PRDM2.
Proteases & Inhibitors: ADAM23, CST6, CTSZ, KLK10, THBS1, TIMP3.
Caveolae Protein: CAV1.
Nuclear Receptors: ESR1, PGR, RARB, RBP1.
Hormones & Receptors: ESR1, PGR.
Histidine Triad Gene Family: FHIT.
Ras Associated Protein Superfamily: RRAD, RASSF1.
WNT Signaling Protein: SFRP1, SFRP2, WIF1.

39

Others: CALCA, EPB41L3, PDLIM4, RARRES1.

Sample & Assay Technologies
EpiTect Biomarker Discovery
Genomic DNA from 10 breast cancer, 1
prostate cancer cell line and normal
human breast tissue was isolated and
analyzed with the EpiTect Human Breast
Cancer Complete Panel PCR Array. The
heat map compares the methylation levels
of the 94 genes on the array.

CONCLUSION:
EpiTect Methyl II PCR Arrays
can be effectively used to
identify novel methylated
biomarkers.

40
Sample & Assay Technologies
EpiTect Biomarker Discovery
What’s next?
Verify gene expression
Using RT2 Profiler
PCR Arrays
Focus on individual
CpG sites by
pyrosequencing

41
Sample & Assay Technologies
Topics for Discussion
Introduction
DNA Methylation Overview
Challenges & Solutions

The EpiTect Methyl II PCR Array System
Principle and Protocol

Research Applications
Pyrosequencing
Summary

42
Sample & Assay Technologies
Site Specific DNA Methylation Analysis
Using Bisulfite Treatment
Importance

m

GG T C AG T G A CG

Crucial step to analyze CpG methylation
Required to distinguish between methylated and

Bisulfite Conversion

GG T U AG T G A CG
PCR

unmethylated cytosines

GG T T AG T G A CG
GG T C AG T G A CG
Bisulfite Conversion

GG T U AG T G A UG
Cells
Blood

PCR

Bisulfite treatment
converts
unmethylated
C into U

gDNA

Converted
DNA

GG T T AG T G A T G

Analysis

Biopsies

Paraffin
slides
43
Sample & Assay Technologies
The Principle of Pyrosequencing Technology
Workflow

~ 2h

Assay Design

PCR
Region of interest
amplified with a
biotinylated primer

~ 15 min

Sample prep

~ 10-60 min

Pyrosequencing

Separation to single
stranded DNA using
streptavidin-coated
beads.

Sequencing-by-synthesis.
Sequence data generated
from the first base next to
the sequencing primer.

Annealing of sequencing
primer.

Sequence context as built in
control

44
Sample & Assay Technologies
Instrument overview
Software functionality and application areas
PyroMark Q24

PyroMark Q96 ID

PyroMark Q96 MD

PyroMark Q96 MD
Automated

Throughput

1–24 samples

1–96 samples

1–96 samples

10–960 with automation
option

Running volume

25 µl

40 µl

12 µl

12 µl

PCR
requirements

10–20 µl
(~1-3 pmol of product)

20–40 µl
(2-4 pmol of product)

5–10 µl
(0.5-1.5 pmol of product)

5–10 µl
(0.5-1.5 pmol of product)

Read lengths
(estimates)

SQA
SNP
AQ
CpG

SQA
SNP
AQ
CpG

SNP
AQ
CpG

SNP
AQ
CpG

Main
applications

Genetic testing
Epigenetics
Microbilogy

Genetic testing
Epigenetics
Microbiology

Epigenetics
Genetic testing

Epigenetics
Genetic testing
(SNP/AQ only in batch
mode)

Sensitivity

5% mutation
95% wt

10% mutation
90% wt

2% mutation
98% wt

2% mutation
98% wt

~50 – 100 bp
~10 – 100 bp
~10 – 100 bp
~10 – 120 bp

~40 – 70 bp
~10 – 100 bp
~10 – 100 bp
~10 – 120 bp

~10 – 100 bp
~10 – 100 bp
~10 – 140 bp

~10 – 100 bp
~10 – 100 bp
~10 – 140 bp

45
** Additional Software (SW) (PyroMark CpG SW) needed on ID and MD instruments

Sample & Assay Technologies
Pyrosequencing for DNA Methylation Analysis
PyroMark CpG Assays – Release Information
PyroMark CpG Assays
PyroMark CpG Assays
Pre-designed
DNA-methylation assays

Human
Number of assays: over 30,000
Number of CpG Islands with assay: ~12,000
(~80%)
Mouse
Number of assays: over 30,000
Number of CpG Islands with assay: ~11,000
(<80%)

46
Sample & Assay Technologies
Pyrosequencing Workflow
PCR
Can Use Any PCR Machine / PCR Reagents / Compatible with Q-PCR
Amplify relevant region by PCR (60 - 1000 bp)
Can Use Very Short PCR Products if Desired (i.e. Degraded DNA)
One primer is biotinylated

PCR primer

Region of interest
PCR primer
biotinylated

47
Sample & Assay Technologies
Pyrosequencing Workflow
Sample preparation
Assay Design

PCR

Sample prep

Pyrosequencing

Immobilize biotinylated PCR
products onto streptavidin coated beads
Separate strands by denaturation in NaOH
Wash/neutralize the immobilized strand
Anneal sequencing primer

48
Sample & Assay Technologies
Pyrosequencing for DNA Methylation Analysis
Analyzing a Pyrogram for DNA-methylation
Sequence to be analyzed:

•

AGTTAC GAC
m

•
After bisulfite
conversion:

AG T TAC GAC•

and A G T T A C G A C
•

•

AG TTATGAT •

and A G T T A C G A T
•

Biotinylated PCR strand:

49
Sample & Assay Technologies
Pyrosequencing for DNA Methylation Analysis
Analyzing a Pyrogram for DNA-methylation
Sequence to be analyzed:

•

AGTTAC GAC
m

•
After bisulfite
conversion:

AG T TAC GAC•

and A G T T A C G A C
•

•

AG TTATGAT •

and A G T T A C G A T
•

Biotinylated PCR strand:
Analyzed sequence:
CpG methylation level:

50
Sample & Assay Technologies
Pyrosequencing for DNA Methylation Analysis
A Range of Analysis Possibilities
Any single CpG site
A4: TAYGGTTTGTA
57%
200
150
100
50
0
E

S

A

T

G

A

T

C

G

T

G

5

Multiple consecutive CpG sites

B 7 : Y G G T A T G T G G A T A T T T T Y G Y G T G G G T A T T T T T AYGGGGAT AT T T T GGT T AT YGT YGYGYGGAT AT T T T T AYGAGGAT AT T T YGGT YGYGYGGAT AT T T AT YGYGGGGAY
37%

35%

36%

33%

33%

32%

33%

30%

31%

38%

37%

29%

36%

30%

31%

34%

34%

2000
1500
1000
500
0
E S A TCGT A TGTGA TCGA T TC TG TCGTGTA TC TGA TC GGA TA T TGTCGA TCA GTC TGTCAGTCGA T A TC TGA TCGAGA TGA T TC TGTCAGTC TGT CGA TA TCGA TCAGTC GGTA TCAGT TCGA T
5

10

15

20

25

30

35

40

45

50

55

60

65

70

75

80

85

90

95

100

105

110

115

120

One gene at a time
Several genes in the same analysis (analyze up to 96 different assays in one run)
Global methylation level
Estimate the global methylation levels using repetitive elements
51
Sample & Assay Technologies
Topics for Discussion
Introduction
DNA Methylation Overview
Challenges & Solutions

The EpiTect Methyl II PCR Array System
Principle and Protocol

Research Applications
Pyrosequencing
Summary

52
Sample & Assay Technologies
DNA Methylation Analysis at QIAGEN
Complete Solution from Sample Isolation through Data Analysis
DNA Methylation is a promising biomarker and is important in regulating
gene expression through several mechanisms

DNA Methylation can be identified using simple restriction digests on a
regional basis using the EpiTect Methyl II PCR Array System
Complete system from DNA isolation through data analysis

DNA Methylation can be identified on site-by-site basis using EpiTect
pyrosequencing
Simple, easy to use system with predesigned assays

53
Sample & Assay Technologies
EpiTect Methyl II PCR System

Pilot Project Starter Offer:
2 Free EpiTect Methyl II Signature Panels or 2 Free EpiTect
Methyl II Assays
With purchase of:
DNA RE Kit
SYBR Green MasterMix
Call 1-888-503-3187
Use Code: FDK-MTFAS22

Outside US and Canada?
Request demo QIAwebinars@QIAGEN.com
54
Sample & Assay Technologies
EpiTect Methyl II Pilot Study
96 and 384 well qPCR Arrays-Human and Mouse
Cancer Related

Pathway-Focused Methyl qPCR Arrays

Breast Cancer

Apoptosis

Epithelial to Mesenchymal
Transition

DNA Repair

Gastric Cancer

Inflammatory Response

Liver Cancer

T Cell Activation

Lung Cancer

Cytokine Production

Prostate Cancer

Tumor Suppressor Genes

Colon Cancer

Homeobox (HOX) Genes

Leukemia & Lymphoma

Polycomb (PcG) Genes

Tumor Suppressor Genes

Cell Cycle

Melanoma

Toll-Like Receptor Signaling

Cancer miRNAs

Stem Cell Transcription Factors

TGF-Beta/BMP Signaling
Wnt Signaling

55
Sample & Assay Technologies
EpiTect Methyl qPCR System

Questions, Comments, Concerns?
US Applications Support
888-503-3187
support@sabiosciences.com
̣

Questions, Comments, Concerns?
Global Applications Support
SAB.EU@qiagen.com

The EpiTect Methyl qPCR Arrays and Assays are intended for molecular biology applications.
This product is not intended for diagnosis, prevention, or treatment of disease.
56
Sample & Assay Technologies

More Related Content

What's hot

Biomarker for genotoxicity 2013
Biomarker for genotoxicity 2013Biomarker for genotoxicity 2013
Biomarker for genotoxicity 2013Elsa von Licy
 
New Technology and Workflow for Integrated Collection, Stabilization and Puri...
New Technology and Workflow for Integrated Collection, Stabilization and Puri...New Technology and Workflow for Integrated Collection, Stabilization and Puri...
New Technology and Workflow for Integrated Collection, Stabilization and Puri...
QIAGEN
 
TaqMan® Rare Mutation Assays w/ Digital PCR | ESHG 2015 Poster PM14.030
TaqMan® Rare Mutation Assays w/ Digital PCR | ESHG 2015 Poster PM14.030TaqMan® Rare Mutation Assays w/ Digital PCR | ESHG 2015 Poster PM14.030
TaqMan® Rare Mutation Assays w/ Digital PCR | ESHG 2015 Poster PM14.030
Thermo Fisher Scientific
 
Breaking the Status Quo: Using Mass Spectrometry to detect Host Cell Proteins
Breaking the Status Quo: Using Mass Spectrometry to detect Host Cell ProteinsBreaking the Status Quo: Using Mass Spectrometry to detect Host Cell Proteins
Breaking the Status Quo: Using Mass Spectrometry to detect Host Cell Proteins
Merck Life Sciences
 
Developing a Rapid Clinical Sequencing System to Classify Meningioma: Meet th...
Developing a Rapid Clinical Sequencing System to Classify Meningioma: Meet th...Developing a Rapid Clinical Sequencing System to Classify Meningioma: Meet th...
Developing a Rapid Clinical Sequencing System to Classify Meningioma: Meet th...
QIAGEN
 
Releasing Your AAV Therapy with Confidence: Regulatory Considerations and Key...
Releasing Your AAV Therapy with Confidence: Regulatory Considerations and Key...Releasing Your AAV Therapy with Confidence: Regulatory Considerations and Key...
Releasing Your AAV Therapy with Confidence: Regulatory Considerations and Key...
Merck Life Sciences
 
New technology and workflow for integrated collection, stabilization and puri...
New technology and workflow for integrated collection, stabilization and puri...New technology and workflow for integrated collection, stabilization and puri...
New technology and workflow for integrated collection, stabilization and puri...
QIAGEN
 
Sequencing 60,000 Samples: An Innovative Large Cohort Study for Breast Cancer...
Sequencing 60,000 Samples: An Innovative Large Cohort Study for Breast Cancer...Sequencing 60,000 Samples: An Innovative Large Cohort Study for Breast Cancer...
Sequencing 60,000 Samples: An Innovative Large Cohort Study for Breast Cancer...
QIAGEN
 
Cell-based Reporter Assays: Measure 45 Signaling Pathway Activity in Any Cel...
 Cell-based Reporter Assays: Measure 45 Signaling Pathway Activity in Any Cel... Cell-based Reporter Assays: Measure 45 Signaling Pathway Activity in Any Cel...
Cell-based Reporter Assays: Measure 45 Signaling Pathway Activity in Any Cel...
Qiagen - Egypt
 
Cell-based Reporter Assays: Measure 45 Signaling Pathway Activity in Any Cell...
Cell-based Reporter Assays: Measure 45 Signaling Pathway Activity in Any Cell...Cell-based Reporter Assays: Measure 45 Signaling Pathway Activity in Any Cell...
Cell-based Reporter Assays: Measure 45 Signaling Pathway Activity in Any Cell...
QIAGEN
 
1073957 wp rt2_profilerapp_1012
1073957 wp rt2_profilerapp_10121073957 wp rt2_profilerapp_1012
1073957 wp rt2_profilerapp_1012Elsa von Licy
 
Circulating Cell Free DNA Targeted Sequencing Workflow | ESHG 2015 Poster PM1...
Circulating Cell Free DNA Targeted Sequencing Workflow | ESHG 2015 Poster PM1...Circulating Cell Free DNA Targeted Sequencing Workflow | ESHG 2015 Poster PM1...
Circulating Cell Free DNA Targeted Sequencing Workflow | ESHG 2015 Poster PM1...
Thermo Fisher Scientific
 
NGS for Infectious Disease Diagnostics: An Opportunity for Growth
NGS for Infectious Disease Diagnostics: An Opportunity for Growth NGS for Infectious Disease Diagnostics: An Opportunity for Growth
NGS for Infectious Disease Diagnostics: An Opportunity for Growth
Alira Health
 
Achieving High Yields in Scalable Xeno Free Culture Formats with Mesenchymal ...
Achieving High Yields in Scalable Xeno Free Culture Formats with Mesenchymal ...Achieving High Yields in Scalable Xeno Free Culture Formats with Mesenchymal ...
Achieving High Yields in Scalable Xeno Free Culture Formats with Mesenchymal ...
Merck Life Sciences
 
2015 11 Inmunoterapia en nsclc
2015 11 Inmunoterapia en nsclc2015 11 Inmunoterapia en nsclc
2015 11 Inmunoterapia en nsclc
Martín Lázaro
 
Biofluid miRNA profiling: from sample to biomarker: miRNA and its Role in Hum...
Biofluid miRNA profiling: from sample to biomarker: miRNA and its Role in Hum...Biofluid miRNA profiling: from sample to biomarker: miRNA and its Role in Hum...
Biofluid miRNA profiling: from sample to biomarker: miRNA and its Role in Hum...
QIAGEN
 
Setting up for successful lot release testing by Edmund Ang
Setting up for successful lot release testing by Edmund AngSetting up for successful lot release testing by Edmund Ang
Setting up for successful lot release testing by Edmund Ang
MilliporeSigma
 
Does your cell line have a secret? Avoid surprises with characterization
Does your cell line have a secret? Avoid surprises with characterizationDoes your cell line have a secret? Avoid surprises with characterization
Does your cell line have a secret? Avoid surprises with characterization
Merck Life Sciences
 
Innovative Molecular Diagnostic Technologies and Emerging Markets
Innovative Molecular Diagnostic Technologies and Emerging MarketsInnovative Molecular Diagnostic Technologies and Emerging Markets
Innovative Molecular Diagnostic Technologies and Emerging MarketsReportsnReports
 
miRNA profiling from blood challenges and recommendations - Download the article
miRNA profiling from blood challenges and recommendations - Download the articlemiRNA profiling from blood challenges and recommendations - Download the article
miRNA profiling from blood challenges and recommendations - Download the article
QIAGEN
 

What's hot (20)

Biomarker for genotoxicity 2013
Biomarker for genotoxicity 2013Biomarker for genotoxicity 2013
Biomarker for genotoxicity 2013
 
New Technology and Workflow for Integrated Collection, Stabilization and Puri...
New Technology and Workflow for Integrated Collection, Stabilization and Puri...New Technology and Workflow for Integrated Collection, Stabilization and Puri...
New Technology and Workflow for Integrated Collection, Stabilization and Puri...
 
TaqMan® Rare Mutation Assays w/ Digital PCR | ESHG 2015 Poster PM14.030
TaqMan® Rare Mutation Assays w/ Digital PCR | ESHG 2015 Poster PM14.030TaqMan® Rare Mutation Assays w/ Digital PCR | ESHG 2015 Poster PM14.030
TaqMan® Rare Mutation Assays w/ Digital PCR | ESHG 2015 Poster PM14.030
 
Breaking the Status Quo: Using Mass Spectrometry to detect Host Cell Proteins
Breaking the Status Quo: Using Mass Spectrometry to detect Host Cell ProteinsBreaking the Status Quo: Using Mass Spectrometry to detect Host Cell Proteins
Breaking the Status Quo: Using Mass Spectrometry to detect Host Cell Proteins
 
Developing a Rapid Clinical Sequencing System to Classify Meningioma: Meet th...
Developing a Rapid Clinical Sequencing System to Classify Meningioma: Meet th...Developing a Rapid Clinical Sequencing System to Classify Meningioma: Meet th...
Developing a Rapid Clinical Sequencing System to Classify Meningioma: Meet th...
 
Releasing Your AAV Therapy with Confidence: Regulatory Considerations and Key...
Releasing Your AAV Therapy with Confidence: Regulatory Considerations and Key...Releasing Your AAV Therapy with Confidence: Regulatory Considerations and Key...
Releasing Your AAV Therapy with Confidence: Regulatory Considerations and Key...
 
New technology and workflow for integrated collection, stabilization and puri...
New technology and workflow for integrated collection, stabilization and puri...New technology and workflow for integrated collection, stabilization and puri...
New technology and workflow for integrated collection, stabilization and puri...
 
Sequencing 60,000 Samples: An Innovative Large Cohort Study for Breast Cancer...
Sequencing 60,000 Samples: An Innovative Large Cohort Study for Breast Cancer...Sequencing 60,000 Samples: An Innovative Large Cohort Study for Breast Cancer...
Sequencing 60,000 Samples: An Innovative Large Cohort Study for Breast Cancer...
 
Cell-based Reporter Assays: Measure 45 Signaling Pathway Activity in Any Cel...
 Cell-based Reporter Assays: Measure 45 Signaling Pathway Activity in Any Cel... Cell-based Reporter Assays: Measure 45 Signaling Pathway Activity in Any Cel...
Cell-based Reporter Assays: Measure 45 Signaling Pathway Activity in Any Cel...
 
Cell-based Reporter Assays: Measure 45 Signaling Pathway Activity in Any Cell...
Cell-based Reporter Assays: Measure 45 Signaling Pathway Activity in Any Cell...Cell-based Reporter Assays: Measure 45 Signaling Pathway Activity in Any Cell...
Cell-based Reporter Assays: Measure 45 Signaling Pathway Activity in Any Cell...
 
1073957 wp rt2_profilerapp_1012
1073957 wp rt2_profilerapp_10121073957 wp rt2_profilerapp_1012
1073957 wp rt2_profilerapp_1012
 
Circulating Cell Free DNA Targeted Sequencing Workflow | ESHG 2015 Poster PM1...
Circulating Cell Free DNA Targeted Sequencing Workflow | ESHG 2015 Poster PM1...Circulating Cell Free DNA Targeted Sequencing Workflow | ESHG 2015 Poster PM1...
Circulating Cell Free DNA Targeted Sequencing Workflow | ESHG 2015 Poster PM1...
 
NGS for Infectious Disease Diagnostics: An Opportunity for Growth
NGS for Infectious Disease Diagnostics: An Opportunity for Growth NGS for Infectious Disease Diagnostics: An Opportunity for Growth
NGS for Infectious Disease Diagnostics: An Opportunity for Growth
 
Achieving High Yields in Scalable Xeno Free Culture Formats with Mesenchymal ...
Achieving High Yields in Scalable Xeno Free Culture Formats with Mesenchymal ...Achieving High Yields in Scalable Xeno Free Culture Formats with Mesenchymal ...
Achieving High Yields in Scalable Xeno Free Culture Formats with Mesenchymal ...
 
2015 11 Inmunoterapia en nsclc
2015 11 Inmunoterapia en nsclc2015 11 Inmunoterapia en nsclc
2015 11 Inmunoterapia en nsclc
 
Biofluid miRNA profiling: from sample to biomarker: miRNA and its Role in Hum...
Biofluid miRNA profiling: from sample to biomarker: miRNA and its Role in Hum...Biofluid miRNA profiling: from sample to biomarker: miRNA and its Role in Hum...
Biofluid miRNA profiling: from sample to biomarker: miRNA and its Role in Hum...
 
Setting up for successful lot release testing by Edmund Ang
Setting up for successful lot release testing by Edmund AngSetting up for successful lot release testing by Edmund Ang
Setting up for successful lot release testing by Edmund Ang
 
Does your cell line have a secret? Avoid surprises with characterization
Does your cell line have a secret? Avoid surprises with characterizationDoes your cell line have a secret? Avoid surprises with characterization
Does your cell line have a secret? Avoid surprises with characterization
 
Innovative Molecular Diagnostic Technologies and Emerging Markets
Innovative Molecular Diagnostic Technologies and Emerging MarketsInnovative Molecular Diagnostic Technologies and Emerging Markets
Innovative Molecular Diagnostic Technologies and Emerging Markets
 
miRNA profiling from blood challenges and recommendations - Download the article
miRNA profiling from blood challenges and recommendations - Download the articlemiRNA profiling from blood challenges and recommendations - Download the article
miRNA profiling from blood challenges and recommendations - Download the article
 

Similar to Epi tect methylation qpcr arrays 2013

Drug metabolism and toxicity 2013
Drug metabolism and toxicity 2013Drug metabolism and toxicity 2013
Drug metabolism and toxicity 2013Elsa von Licy
 
2014 11 03_bioinformatics_case_studies
2014 11 03_bioinformatics_case_studies2014 11 03_bioinformatics_case_studies
2014 11 03_bioinformatics_case_studies
Prof. Wim Van Criekinge
 
2015 07 09__epigenetic_profiling_environmental_health_sciences_v42
2015 07 09__epigenetic_profiling_environmental_health_sciences_v422015 07 09__epigenetic_profiling_environmental_health_sciences_v42
2015 07 09__epigenetic_profiling_environmental_health_sciences_v42
Prof. Wim Van Criekinge
 
PROTEASE DETECTION ON BLOOD SPOT CARDS FOR FUTURE COMPANION DIAGNOSTICS
PROTEASE DETECTION ON BLOOD SPOT CARDS FOR FUTURE COMPANION DIAGNOSTICSPROTEASE DETECTION ON BLOOD SPOT CARDS FOR FUTURE COMPANION DIAGNOSTICS
PROTEASE DETECTION ON BLOOD SPOT CARDS FOR FUTURE COMPANION DIAGNOSTICS
iQHub
 
Multiplex Assays for Studying Gene Regulation and Cell Function
Multiplex Assays for Studying Gene Regulation and Cell FunctionMultiplex Assays for Studying Gene Regulation and Cell Function
Multiplex Assays for Studying Gene Regulation and Cell Function
MiraiBio Group of Hitachi Solutions America, Ltd.
 
Total RNA Discovery for RNA Biomarker Development Webinar
Total RNA Discovery for RNA Biomarker Development WebinarTotal RNA Discovery for RNA Biomarker Development Webinar
Total RNA Discovery for RNA Biomarker Development Webinar
QIAGEN
 
2013 10 23_dna_for_dummies_v_presented
2013 10 23_dna_for_dummies_v_presented2013 10 23_dna_for_dummies_v_presented
2013 10 23_dna_for_dummies_v_presented
Prof. Wim Van Criekinge
 
Clinical proteomics in diseases lecture, 2014
Clinical proteomics in diseases lecture, 2014Clinical proteomics in diseases lecture, 2014
Clinical proteomics in diseases lecture, 2014
Mohammad Hessam Rafiee
 
Ai Biotech Mktg Overview 0411
Ai Biotech Mktg Overview 0411Ai Biotech Mktg Overview 0411
Ai Biotech Mktg Overview 0411Adam Libby
 
BioMAP<sup>®</sup> Primary Human Cell-Based Systems for Drug Discovery
BioMAP<sup>®</sup> Primary Human Cell-Based Systems for Drug DiscoveryBioMAP<sup>®</sup> Primary Human Cell-Based Systems for Drug Discovery
BioMAP<sup>®</sup> Primary Human Cell-Based Systems for Drug Discovery
BioMAP® Systems
 
Keeping Up With Advances in Cancer Immunotherapy and Biomarker Testing: Impli...
Keeping Up With Advances in Cancer Immunotherapy and Biomarker Testing: Impli...Keeping Up With Advances in Cancer Immunotherapy and Biomarker Testing: Impli...
Keeping Up With Advances in Cancer Immunotherapy and Biomarker Testing: Impli...
PVI, PeerView Institute for Medical Education
 
2014 11-27 EATRIS biomarkers platform, Amsterdam, oncology case study
2014 11-27 EATRIS biomarkers platform, Amsterdam, oncology case study2014 11-27 EATRIS biomarkers platform, Amsterdam, oncology case study
2014 11-27 EATRIS biomarkers platform, Amsterdam, oncology case study
Alain van Gool
 
Clinical molecular diagnostics for drug guidance
Clinical molecular diagnostics for drug guidanceClinical molecular diagnostics for drug guidance
Clinical molecular diagnostics for drug guidance
Nikesh Shah
 
Reporter assay and q pcr application 2012
Reporter assay and q pcr application 2012Reporter assay and q pcr application 2012
Reporter assay and q pcr application 2012Elsa von Licy
 
SNOMED CT concept model for molecular pathology_final.pptx
SNOMED CT concept model for molecular pathology_final.pptxSNOMED CT concept model for molecular pathology_final.pptx
SNOMED CT concept model for molecular pathology_final.pptx
HariHaran685388
 
Microarrays;application
Microarrays;applicationMicroarrays;application
Microarrays;applicationFyzah Bashir
 
Provenge (sipuleucel t)
Provenge (sipuleucel t)Provenge (sipuleucel t)
Provenge (sipuleucel t)Vinblast
 

Similar to Epi tect methylation qpcr arrays 2013 (20)

Drug metabolism and toxicity 2013
Drug metabolism and toxicity 2013Drug metabolism and toxicity 2013
Drug metabolism and toxicity 2013
 
Pp adna epi_tect
Pp adna epi_tectPp adna epi_tect
Pp adna epi_tect
 
2014 11 03_bioinformatics_case_studies
2014 11 03_bioinformatics_case_studies2014 11 03_bioinformatics_case_studies
2014 11 03_bioinformatics_case_studies
 
2015 07 09__epigenetic_profiling_environmental_health_sciences_v42
2015 07 09__epigenetic_profiling_environmental_health_sciences_v422015 07 09__epigenetic_profiling_environmental_health_sciences_v42
2015 07 09__epigenetic_profiling_environmental_health_sciences_v42
 
PROTEASE DETECTION ON BLOOD SPOT CARDS FOR FUTURE COMPANION DIAGNOSTICS
PROTEASE DETECTION ON BLOOD SPOT CARDS FOR FUTURE COMPANION DIAGNOSTICSPROTEASE DETECTION ON BLOOD SPOT CARDS FOR FUTURE COMPANION DIAGNOSTICS
PROTEASE DETECTION ON BLOOD SPOT CARDS FOR FUTURE COMPANION DIAGNOSTICS
 
Multiplex Assays for Studying Gene Regulation and Cell Function
Multiplex Assays for Studying Gene Regulation and Cell FunctionMultiplex Assays for Studying Gene Regulation and Cell Function
Multiplex Assays for Studying Gene Regulation and Cell Function
 
Total RNA Discovery for RNA Biomarker Development Webinar
Total RNA Discovery for RNA Biomarker Development WebinarTotal RNA Discovery for RNA Biomarker Development Webinar
Total RNA Discovery for RNA Biomarker Development Webinar
 
2013 10 23_dna_for_dummies_v_presented
2013 10 23_dna_for_dummies_v_presented2013 10 23_dna_for_dummies_v_presented
2013 10 23_dna_for_dummies_v_presented
 
Brian_Strahl 2013_class_on_genomics_and_proteomics
Brian_Strahl 2013_class_on_genomics_and_proteomicsBrian_Strahl 2013_class_on_genomics_and_proteomics
Brian_Strahl 2013_class_on_genomics_and_proteomics
 
Clinical proteomics in diseases lecture, 2014
Clinical proteomics in diseases lecture, 2014Clinical proteomics in diseases lecture, 2014
Clinical proteomics in diseases lecture, 2014
 
Ai Biotech Mktg Overview 0411
Ai Biotech Mktg Overview 0411Ai Biotech Mktg Overview 0411
Ai Biotech Mktg Overview 0411
 
BioMAP<sup>®</sup> Primary Human Cell-Based Systems for Drug Discovery
BioMAP<sup>®</sup> Primary Human Cell-Based Systems for Drug DiscoveryBioMAP<sup>®</sup> Primary Human Cell-Based Systems for Drug Discovery
BioMAP<sup>®</sup> Primary Human Cell-Based Systems for Drug Discovery
 
Keeping Up With Advances in Cancer Immunotherapy and Biomarker Testing: Impli...
Keeping Up With Advances in Cancer Immunotherapy and Biomarker Testing: Impli...Keeping Up With Advances in Cancer Immunotherapy and Biomarker Testing: Impli...
Keeping Up With Advances in Cancer Immunotherapy and Biomarker Testing: Impli...
 
Ngs part ii 2013
Ngs part ii 2013Ngs part ii 2013
Ngs part ii 2013
 
2014 11-27 EATRIS biomarkers platform, Amsterdam, oncology case study
2014 11-27 EATRIS biomarkers platform, Amsterdam, oncology case study2014 11-27 EATRIS biomarkers platform, Amsterdam, oncology case study
2014 11-27 EATRIS biomarkers platform, Amsterdam, oncology case study
 
Clinical molecular diagnostics for drug guidance
Clinical molecular diagnostics for drug guidanceClinical molecular diagnostics for drug guidance
Clinical molecular diagnostics for drug guidance
 
Reporter assay and q pcr application 2012
Reporter assay and q pcr application 2012Reporter assay and q pcr application 2012
Reporter assay and q pcr application 2012
 
SNOMED CT concept model for molecular pathology_final.pptx
SNOMED CT concept model for molecular pathology_final.pptxSNOMED CT concept model for molecular pathology_final.pptx
SNOMED CT concept model for molecular pathology_final.pptx
 
Microarrays;application
Microarrays;applicationMicroarrays;application
Microarrays;application
 
Provenge (sipuleucel t)
Provenge (sipuleucel t)Provenge (sipuleucel t)
Provenge (sipuleucel t)
 

More from Elsa von Licy

Styles of Scientific Reasoning, Scientific Practices and Argument in Science ...
Styles of Scientific Reasoning, Scientific Practices and Argument in Science ...Styles of Scientific Reasoning, Scientific Practices and Argument in Science ...
Styles of Scientific Reasoning, Scientific Practices and Argument in Science ...
Elsa von Licy
 
Strategie Decisions Incertitude Actes conference fnege xerfi
Strategie Decisions Incertitude Actes conference fnege xerfiStrategie Decisions Incertitude Actes conference fnege xerfi
Strategie Decisions Incertitude Actes conference fnege xerfi
Elsa von Licy
 
Rainville pierre
Rainville pierreRainville pierre
Rainville pierre
Elsa von Licy
 
Neuropsychophysiologie
NeuropsychophysiologieNeuropsychophysiologie
Neuropsychophysiologie
Elsa von Licy
 
L agressivite en psychanalyse (21 pages 184 ko)
L agressivite en psychanalyse (21 pages   184 ko)L agressivite en psychanalyse (21 pages   184 ko)
L agressivite en psychanalyse (21 pages 184 ko)
Elsa von Licy
 
C1 clef pour_la_neuro
C1 clef pour_la_neuroC1 clef pour_la_neuro
C1 clef pour_la_neuro
Elsa von Licy
 
Hemostase polycop
Hemostase polycopHemostase polycop
Hemostase polycop
Elsa von Licy
 
Vuillez jean philippe_p01
Vuillez jean philippe_p01Vuillez jean philippe_p01
Vuillez jean philippe_p01
Elsa von Licy
 
Spr ue3.1 poly cours et exercices
Spr ue3.1   poly cours et exercicesSpr ue3.1   poly cours et exercices
Spr ue3.1 poly cours et exercices
Elsa von Licy
 
Plan de cours all l1 l2l3m1m2 p
Plan de cours all l1 l2l3m1m2 pPlan de cours all l1 l2l3m1m2 p
Plan de cours all l1 l2l3m1m2 p
Elsa von Licy
 
M2 bmc2007 cours01
M2 bmc2007 cours01M2 bmc2007 cours01
M2 bmc2007 cours01
Elsa von Licy
 
Bioph pharm 1an-viscosit-des_liquides_et_des_solutions
Bioph pharm 1an-viscosit-des_liquides_et_des_solutionsBioph pharm 1an-viscosit-des_liquides_et_des_solutions
Bioph pharm 1an-viscosit-des_liquides_et_des_solutions
Elsa von Licy
 
Poly histologie-et-embryologie-medicales
Poly histologie-et-embryologie-medicalesPoly histologie-et-embryologie-medicales
Poly histologie-et-embryologie-medicales
Elsa von Licy
 
Methodes travail etudiants
Methodes travail etudiantsMethodes travail etudiants
Methodes travail etudiants
Elsa von Licy
 
Atelier.etude.efficace
Atelier.etude.efficaceAtelier.etude.efficace
Atelier.etude.efficace
Elsa von Licy
 
There is no_such_thing_as_a_social_science_intro
There is no_such_thing_as_a_social_science_introThere is no_such_thing_as_a_social_science_intro
There is no_such_thing_as_a_social_science_intro
Elsa von Licy
 

More from Elsa von Licy (20)

Styles of Scientific Reasoning, Scientific Practices and Argument in Science ...
Styles of Scientific Reasoning, Scientific Practices and Argument in Science ...Styles of Scientific Reasoning, Scientific Practices and Argument in Science ...
Styles of Scientific Reasoning, Scientific Practices and Argument in Science ...
 
Strategie Decisions Incertitude Actes conference fnege xerfi
Strategie Decisions Incertitude Actes conference fnege xerfiStrategie Decisions Incertitude Actes conference fnege xerfi
Strategie Decisions Incertitude Actes conference fnege xerfi
 
Rainville pierre
Rainville pierreRainville pierre
Rainville pierre
 
Neuropsychophysiologie
NeuropsychophysiologieNeuropsychophysiologie
Neuropsychophysiologie
 
L agressivite en psychanalyse (21 pages 184 ko)
L agressivite en psychanalyse (21 pages   184 ko)L agressivite en psychanalyse (21 pages   184 ko)
L agressivite en psychanalyse (21 pages 184 ko)
 
C1 clef pour_la_neuro
C1 clef pour_la_neuroC1 clef pour_la_neuro
C1 clef pour_la_neuro
 
Hemostase polycop
Hemostase polycopHemostase polycop
Hemostase polycop
 
Antiphilos
AntiphilosAntiphilos
Antiphilos
 
Vuillez jean philippe_p01
Vuillez jean philippe_p01Vuillez jean philippe_p01
Vuillez jean philippe_p01
 
Spr ue3.1 poly cours et exercices
Spr ue3.1   poly cours et exercicesSpr ue3.1   poly cours et exercices
Spr ue3.1 poly cours et exercices
 
Plan de cours all l1 l2l3m1m2 p
Plan de cours all l1 l2l3m1m2 pPlan de cours all l1 l2l3m1m2 p
Plan de cours all l1 l2l3m1m2 p
 
M2 bmc2007 cours01
M2 bmc2007 cours01M2 bmc2007 cours01
M2 bmc2007 cours01
 
Feuilletage
FeuilletageFeuilletage
Feuilletage
 
Chapitre 1
Chapitre 1Chapitre 1
Chapitre 1
 
Biophy
BiophyBiophy
Biophy
 
Bioph pharm 1an-viscosit-des_liquides_et_des_solutions
Bioph pharm 1an-viscosit-des_liquides_et_des_solutionsBioph pharm 1an-viscosit-des_liquides_et_des_solutions
Bioph pharm 1an-viscosit-des_liquides_et_des_solutions
 
Poly histologie-et-embryologie-medicales
Poly histologie-et-embryologie-medicalesPoly histologie-et-embryologie-medicales
Poly histologie-et-embryologie-medicales
 
Methodes travail etudiants
Methodes travail etudiantsMethodes travail etudiants
Methodes travail etudiants
 
Atelier.etude.efficace
Atelier.etude.efficaceAtelier.etude.efficace
Atelier.etude.efficace
 
There is no_such_thing_as_a_social_science_intro
There is no_such_thing_as_a_social_science_introThere is no_such_thing_as_a_social_science_intro
There is no_such_thing_as_a_social_science_intro
 

Epi tect methylation qpcr arrays 2013

  • 1. EpiTect Methyl II PCR Array System Samuel J. Rulli, Jr., Ph. D. Epigenetics Applications Scientist Samuel.Rulli@QIAGEN.com QIAwebinars@QIAGEN.com The EpiTect Methyl qPCR Arrays and Assays are intended for molecular biology applications. This product is not intended for diagnosis, prevention, or treatment of disease. 1 Sample & Assay Technologies
  • 2. EpiTect Methyl II PCR Array System Questions, Comments, Concerns? US Applications Support 888-503-3187 support@sabiosciences.com ̣ Questions, Comments, Concerns? Global Applications Support SAB.EU@qiagen.com The EpiTect Methyl II PCR Arrays and Assays are intended for molecular biology applications. This product is not intended for diagnosis, prevention, or treatment of disease. 2 Sample & Assay Technologies
  • 3. Disclaimer and intended use EpiTect Methyl II PCR Array product line EpiTect® Kits are intended for molecular biology applications. These products are not intended for the diagnosis, prevention, or treatment of a disease. The EpiTect Methyl II qPCR system enables pathway or disease-focused profiling of regional DNA methylation using MethylScreen™ technology provided under license from Orion Genomics, LLC. For up-to-date licensing information and productspecific disclaimers, see the respective QIAGEN kit handbook or user manual. QIAGEN kit handbooks and user manuals are available at www.qiagen.com or can be requested from QIAGEN Technical Services or your local distributor. ̣ 3 Sample & Assay Technologies
  • 4. Topics for Discussion Introduction DNA Methylation Overview Challenges & Solutions The EpiTect Methyl II PCR Array System Principle and Protocol Research Applications Pyrosequencing Summary 4 Sample & Assay Technologies
  • 5. Basic Gene Expression Model Protein “A” mRNA ”A” Structural Gene “A” 5 Sample & Assay Technologies
  • 6. The Current Model Activated Transcription Factors RNAi: shRNA miRNA Protein “A” NFκB + p53 Transcription Initiation Complex mRNA ”A” – Histones p53 BS Me Me Me Me Me NFκB BS DNA Methylation Histone-DNA Interactions Ac Me Me Me Structural Gene “A” or Reporter system DNA Methylation 6 Sample & Assay Technologies
  • 7. The Current Model Activated Transcription Factors RNAi: shRNA miRNA Protein “A” NFκB + p53 Transcription Initiation Complex mRNA ”A” – Histones p53 BS Me Me Me Me Me NFκB BS DNA Methylation Histone-DNA Interactions Ac Me Me Me Structural Gene “A” TSS (+1) or Reporter system DNA Methylation 7 Sample & Assay Technologies
  • 8. DNA Methylation: Introduction NH2 N O N H NH2 H +DNMT O CH3 N S-Enz AdoMet AdoHcy R N NH2 -DNMT N CH3 O N 5-methyl-cytosine cytosine Stable, covalent DNA modification that targets CpG dinucleotides 70%-80% of the CpG dinucleotides are methylated in healthy mammalian cells These methylated regions are typical of the bulk chromatin that is relatively inaccessible to transcription factors. Associated with gene silencing 1 Normal 2 3 Expression Promoter Region Cancer Adapted from Herman, J. and Baylin, S. N. Engl. J. Med. 2003 1 2 3 No Expression CpG islands: CpG-rich regions in human gene promoters Promoter CpG islands are usually unmethylated in normal tissues. Exceptions include genes involved in X-chromosome inactivation, gene imprinting and tissue-specific expression. 8 Sample & Assay Technologies
  • 9. DNA Methylation and Transcriptional Repression 9 Blood, 93:4059-4070, 1999 Sample & Assay Technologies
  • 10. Critical Biological Roles for DNA Methylation Roles in normal development and disease progression Potentially silences expression of critical tumor suppressors Involves all cellular pathways Methylated DNA can be detected in heterogenous fluids Breast cancer: nipple aspirate Lung cancer: bronchoalveolar lavage Prostate cancer: urine Multiple cancers: plasma and serum DNA Methylation: Promising Biomarker Early detection Predicting prognosis Mechanism of Action for Therapy Resistance/ Therapy Choice 10 Sample & Assay Technologies
  • 11. Challenges in Existing Technologies Current Workflow for DNA Methylation Analysis: Commonly used pretreatment – sodium bisulfite conversion Methods of analysis – Pyrosequencing, Methylation-specific PCR (MSP), bisulfite sequencing, next-generation sequencing, MALDI-TOF MS, etc. Benefits – Single-base resolution of methylome Drawbacks – Protocol Optimization, laborious for many samples, need for specialized equipment WHY EpiTect Methyl II qPCR System? Available for any laboratory with qPCR instrument Complete System- Sample Isolation to DATA Analysis Regional Methylation Pattern More Biology - Less Time Complimentary to Bisulfite Based Methods 11 Sample & Assay Technologies
  • 12. Site Specific DNA Methylation Analysis Using Bisulfite Treatment m G T C AG T G A CG G T C AG T G A CG Bisulfite Conversion Bisulfite Conversion G T U AG T G A CG G T U AG T G A UG PCR G T T AG T G A CG PCR G T T AG T G A T G 12 Sample & Assay Technologies
  • 13. Challenges in Existing Technologies Current Workflow for DNA Methylation Analysis: Commonly used pretreatment – sodium bisulfite conversion Methods of analysis – Pyrosequencing, Methylation-specific PCR (MSP), bisulfite sequencing, next-generation sequencing, MALDI-TOF MS, etc. Benefits – Single-base resolution of methylome Drawbacks – Protocol Optimization, laborious for many samples, need for specialized equipment WHY EpiTect Methyl II qPCR System? Available for any laboratory with qPCR instrument Complete System- Sample Isolation to DATA Analysis Regional Methylation Pattern More Biology - Less Time Complimentary to Bisulfite Based Methods 13 Sample & Assay Technologies
  • 14. Topics for Discussion Introduction DNA Methylation Overview Challenges & Solutions The EpiTect Methyl II PCR Array System Principle and Protocol Research Applications Pyrosequencing Summary 14 Sample & Assay Technologies
  • 15. EpiTect DNA Methylation PCR System Complete Solution from Sample Isolation through Data Analysis DNA Isolation: QIAGEN Blood and Tissue Kit EpiTect Methyl II DNA Restriction Kit For fresh/frozen tissues and cells EpiTect Methyl II PCR Arrays 96 or 384 well format compatible with most qPCR instruments Cataloged - multiple assays (24 or 96) on one PCR Plate Custom - available for every promoter in the human, mouse, and rat genome EpiTect Methyl II PCR Assays Primers for every promoter in the human, mouse, or rat genome with CpG island EpiTect qPCR primer assay search portal Optimized RT2 SYBR Green Master Mix EpiTect Methyl II Data Analysis (Excel template) 15 Sample & Assay Technologies
  • 16. DNA Methylation PCR Array Protocol Overview (0.5 – 4 ug of Genomic DNA) 16 Sample & Assay Technologies
  • 17. DNA Methylation PCR Array Protocol Overview Sample Preparation: QIAGEN DNeasy Blood and Tissue Kit 17 Sample & Assay Technologies
  • 18. DNA Methylation PCR Array Protocol Overview (0.5 – 4 ug of Genomic DNA) 18 Sample & Assay Technologies
  • 19. How It Works: Principle behind EpiTect Methyl II PCR Array Based on the quantitative detection of remaining target DNA molecules after treatment with a Methylation-sensitive (MSRE) and a Methylationdependent (MDRE) restriction enzyme mixtures. Enzyme How It Works Remaining DNA MOCK No enzyme added Input fraction MSRE Digests unmethylated and partially methylated DNA copies Methylated fraction MDRE Digests methylated and partially methylated DNA copies Unmethylated fraction MSRE & MDRE (Double) Digests unmethylated, partially methylated, and methylated DNA copies Fraction resistant to enzyme digestion (Analytical window) 19 Sample & Assay Technologies
  • 20. DNA Methylation PCR Array Protocol Overview (0.5 – 4 ug of Genomic DNA) 20 Sample & Assay Technologies
  • 21. DNA Methylation PCR Array Protocol Overview (0.5 – 4 ug of Genomic DNA) Which EpiTect Methyl II PCR Array do I use? 21 Sample & Assay Technologies
  • 22. “Catalogued” EpiTect Methyl II PCR Arrays Simultaneously analyze the DNA methylation status of 22- or 94-gene panels associated with specific cancer types, other diseases or biological pathways. 96 and 384 well qPCR Arrays-Human and Mouse Cancer Related Pathway-Focused Methyl qPCR Arrays Breast Cancer Apoptosis Epithelial to Mesenchymal Transition DNA Repair Gastric Cancer Inflammatory Response Liver Cancer T Cell Activation Lung Cancer Cytokine Production Prostate Cancer Tumor Suppressor Genes Colon Cancer Homeobox (HOX) Genes Leukemia & Lymphoma Polycomb (PcG) Genes Tumor Suppressor Genes Cell Cycle Melanoma Toll-Like Receptor Signaling Cancer miRNAs Stem Cell Transcription Factors TGF-Beta/BMP Signaling Wnt Signaling Custom Arrays and Custom Assays Are Available Available for most CpG island-containing promoter in the human, mouse, or rat genome. 22 http://www.sabiosciences.com/dna_methylation_custom_PCRarray.php Sample & Assay Technologies
  • 23. DNA Methylation PCR Array Protocol Overview (0.5 – 4 ug of Genomic DNA) Data Analysis 23 Sample & Assay Technologies
  • 24. EpiTect Data Analysis Excel Analysis Templates Quickly Understand the Biology: Results automatically calculated, analyzed, and annotated No Software to download, license or install: Simply paste in your raw Ct values 24 Sample & Assay Technologies
  • 25. Advantages of the EpiTect Methyl II PCR System Single Gene, Pathway or Disease-Focused Analysis Screen large number of samples for few genes with single assays Simultaneously detect the methylation status of 22-94 genes Compliments & validates genome-wide methylation studies Fast, Reliable & Sensitive Direct measurement of methylated & unmethylated DNA Similar results and sensitivity as bisulfite sequencing, with no bisulfite conversion Higher throughput than bisulfite-PCR Highly reproducible Genome-Wide Coverage Primers detecting methylation status of any human, mouse, or rat gene with predicted CpG island Bench-validated qPCR primers 25 Sample & Assay Technologies
  • 26. EpiTect Methyl II PCR Array Principle: Representational design Unmethylated Unmethylated Hypermethylated qPCR results Four selective methylation-specific digestion restriction 26 Sample & Assay Technologies
  • 27. EpiTect Methyl II PCR Array Principle: Representational design Sample 1 Sample 2 Unmethylated 1 Unmethylated Hypermethylated methylated 1 qPCR results Each CpG Island is interrogated at multiple sites for both RE Digests Unbiased qPCR since both primers are the same (valid ∆Ct calculations) Internal Standard for each Assay (mock digest versus total digest) Representational Design Four selective methylation-specific digestion restriction 27 Sample & Assay Technologies
  • 28. EpiTect Methyl II PCR Assays Targets Primers available for approximately 13,000 promoter CpG islands Design includes CpG island or CpG dense areas associated with a transcription start site (TSS) CpG island & TSS definitions: UCSC Genome Bioinformatics Site & NCBI Each assay corresponds to one distinct CpG island in a promoter region EpiTect Methyl qPCR Assay Search Portal: http://www.sabiosciences.com/dna_methylation_qPCRprimer.php Amplicon Specifics Selected from 5 kb upstream to 3 kb downstream of TSS Each includes at least three or more of both MSRE and MDRE restriction sites Size: 150 to 400 bp (240 bp average) 28 Sample & Assay Technologies
  • 29. Laboratory QC Validation of ALL EpiTect Methyl II PCR Assays & Arrays All EpiTect Methyl II PCR Arrays and Assays are laboratory validated: Assays in each PCR Array are tested for Sensitivity: Constant C(t) value for same amount of template Amplification Efficiency: Single curve analysis and standard curve dilutions Specificity: Single melt-peak during dissociation Validation is done on every lot of primers and every EpiTect Methyl II PCR Array Performance of all EpiTect Methyl II PCR Assays is guaranteed when used with the RT2 SYBR-Green qPCR Mastermix 29 Sample & Assay Technologies
  • 30. EpiTect Methyl qPCR Assay Efficiency Amplification Efficiency Amplification and Dissociation Curves 140% PCR Efficiency 120% 100% 80% 60% Mouse 40% Human 20% 0% 0 100 200 300 400 500 Amplicon length in bp Unique qPCR cycling Conditions (critical for assay performance) Validated Primer Specificity & High Amplification Efficiency Similar Amplification Efficiencies for Each Primer Pair 30 Sample & Assay Technologies
  • 31. Melting Curve Analysis Single Dissociation Peaks for Every Gene Assay Example of QC criteria for every PCR Assay manufactured by SABiosciences Single peak dissociation curves Single gel bands of predicted size 31 Sample & Assay Technologies
  • 32. Melting Curve Analysis Single Dissociation Peaks for Every Gene Assay Example of QC criteria for every PCR Assay manufactured by SABiosciences Single peak dissociation curves Single gel bands of predicted size 32 Sample & Assay Technologies
  • 33. Melting Curve Analysis Single Dissociation Peaks for Every Gene Assay Example of QC criteria for every PCR Assay manufactured by SABiosciences Single peak dissociation curves Single gel bands of predicted size 33 Sample & Assay Technologies
  • 34. EpiTect Methyl II PCR Arrays Comparable to Bisulfite Sequencing CDH13 MCF7 MB231 HeLa Unmethylated CpG sites Methylated CpG sites EpiTect Methyl II PCR Assays generated quantitative methylation data comparable to bisulfite sequencing data. 34 Sample & Assay Technologies
  • 35. EpiTect Methyl qPCR Assay Sensitivity PERCENTAGE OF TOTAL INPUT DNA SENSITIVITY COMPARABLE TO BISULFITE SEQUENCING 100.00% 90.00% 80.00% 70.00% 60.00% 50.00% Unmethylated 40.00% Methylated 30.00% 20.00% 10.00% 0.00% 100.0 75.0 50.0 33.3 12.5 6.3 PERCENT SKBR3 GENOMIC DNA (%) 0.0 Methylated tumor DNA detectable in heterogeneous samples containing as little as 5% tumor. 35 Sample & Assay Technologies
  • 36. EpiTect Methyl II PCR Arrays Comparable to Illumina Infinium BeadChip Comparison between 94 CpG sites (22 shown) important for breast cancers in MCF-7 cells Similar results between 2 different platforms using different preparation methods Methyl II PCR assays can be used to validate results from large scale screening projects 36 Sample & Assay Technologies
  • 37. Topics for Discussion Introduction DNA Methylation Overview Challenges & Solutions The EpiTect Methyl II PCR Array System Principle and Protocol Research Applications Pyrosequencing Summary 37 Sample & Assay Technologies
  • 38. Research Applications: Methylation in Breast Cancer Is there a difference in the Methylation status of breast cancer associated genes among commonly used Breast Cancer Cell lines? Obtained genomic DNA from Human Breast Cancer Cell lines (ATCC) Normal Breast Tissue (Capital Bioscience) EpiTect Methyl II Breast Cancer PCR Array 38 Sample & Assay Technologies
  • 39. Human Breast Cancer EpiTect Methyl II Complete PCR Array: Functional gene groupings Cell Cycle, Growth, Differentiation & Development: APC, ATM, BIRC5, BRCA1, BRCA2, CCNA1, CCND2, CDKN1B, CDKN1C, CDKN2A, CDKN2B, CHFR, GADD45A, GPC3, HOXD11, MEN1, PALB2, RASSF1, SFN (14-3- 3 sigma), TERT, TGFB2, TGFBI, TGFBR1, TP73, TWIST1, VHL, WIF1, WT1, WWOX. Transcription Factors: APC, BRCA1, BRCA2, MYOD1, CDKN2A, CDX2, HIC1, HOXA5, HOXD11, ID4, MSX1, PAX5, PLAGL1, PRDM2, PROX1, RB1, RUNX3, TP73, TWIST1, VHL, WT1, ZMYND10. DNA Damage Repair: APC, BRCA1, BRCA2, GADD45A, MLH1, RASSF1, TERT, VHL, WWOX. Apoptosis & Anti-Apoptosis: APC, BIRC5, BRCA1, BRCA2, DAPK1, MEN1, PYCARD, TNFRSF10C, TNFRSF10D, TP73, VHL, WWOX. Cell Adhesion: APC, CDH1, CDH13, CADM1, CLSTN1, DSC3, EPCAM, JUP, THBS1. Growth Factors: BMP6, IGFBP7, IGFBPL1, WIF1. Chemokine & Cytokine Signaling: CXCL12, TNFRSF10C, TNFRSF10D. Circadian Rhythm: PER1, PER2. Solute Carrier Family: SLC5A8. Drug Metabolism: CYP1B1, GSTP1. Fatty Acid Metabolism: HSD17B4. Heparan Sulfate Biosynthetic Enzymes: HS3ST2, HS3ST3B1. Extracellular Matrix: LOX, MUC2, SLIT2, SLIT3, TGFBI, THBS1, TIMP3, WIF1. Protein Kinase & Protein Kinase Adaptor Proteins: PRKCDBP. Phosphatases: PTEN. Prostaglandin-Endoperoxide Synthase: PTGS2. DNA Methylation: MEN1, MGMT, PRDM2. Proteases & Inhibitors: ADAM23, CST6, CTSZ, KLK10, THBS1, TIMP3. Caveolae Protein: CAV1. Nuclear Receptors: ESR1, PGR, RARB, RBP1. Hormones & Receptors: ESR1, PGR. Histidine Triad Gene Family: FHIT. Ras Associated Protein Superfamily: RRAD, RASSF1. WNT Signaling Protein: SFRP1, SFRP2, WIF1. 39 Others: CALCA, EPB41L3, PDLIM4, RARRES1. Sample & Assay Technologies
  • 40. EpiTect Biomarker Discovery Genomic DNA from 10 breast cancer, 1 prostate cancer cell line and normal human breast tissue was isolated and analyzed with the EpiTect Human Breast Cancer Complete Panel PCR Array. The heat map compares the methylation levels of the 94 genes on the array. CONCLUSION: EpiTect Methyl II PCR Arrays can be effectively used to identify novel methylated biomarkers. 40 Sample & Assay Technologies
  • 41. EpiTect Biomarker Discovery What’s next? Verify gene expression Using RT2 Profiler PCR Arrays Focus on individual CpG sites by pyrosequencing 41 Sample & Assay Technologies
  • 42. Topics for Discussion Introduction DNA Methylation Overview Challenges & Solutions The EpiTect Methyl II PCR Array System Principle and Protocol Research Applications Pyrosequencing Summary 42 Sample & Assay Technologies
  • 43. Site Specific DNA Methylation Analysis Using Bisulfite Treatment Importance m GG T C AG T G A CG Crucial step to analyze CpG methylation Required to distinguish between methylated and Bisulfite Conversion GG T U AG T G A CG PCR unmethylated cytosines GG T T AG T G A CG GG T C AG T G A CG Bisulfite Conversion GG T U AG T G A UG Cells Blood PCR Bisulfite treatment converts unmethylated C into U gDNA Converted DNA GG T T AG T G A T G Analysis Biopsies Paraffin slides 43 Sample & Assay Technologies
  • 44. The Principle of Pyrosequencing Technology Workflow ~ 2h Assay Design PCR Region of interest amplified with a biotinylated primer ~ 15 min Sample prep ~ 10-60 min Pyrosequencing Separation to single stranded DNA using streptavidin-coated beads. Sequencing-by-synthesis. Sequence data generated from the first base next to the sequencing primer. Annealing of sequencing primer. Sequence context as built in control 44 Sample & Assay Technologies
  • 45. Instrument overview Software functionality and application areas PyroMark Q24 PyroMark Q96 ID PyroMark Q96 MD PyroMark Q96 MD Automated Throughput 1–24 samples 1–96 samples 1–96 samples 10–960 with automation option Running volume 25 µl 40 µl 12 µl 12 µl PCR requirements 10–20 µl (~1-3 pmol of product) 20–40 µl (2-4 pmol of product) 5–10 µl (0.5-1.5 pmol of product) 5–10 µl (0.5-1.5 pmol of product) Read lengths (estimates) SQA SNP AQ CpG SQA SNP AQ CpG SNP AQ CpG SNP AQ CpG Main applications Genetic testing Epigenetics Microbilogy Genetic testing Epigenetics Microbiology Epigenetics Genetic testing Epigenetics Genetic testing (SNP/AQ only in batch mode) Sensitivity 5% mutation 95% wt 10% mutation 90% wt 2% mutation 98% wt 2% mutation 98% wt ~50 – 100 bp ~10 – 100 bp ~10 – 100 bp ~10 – 120 bp ~40 – 70 bp ~10 – 100 bp ~10 – 100 bp ~10 – 120 bp ~10 – 100 bp ~10 – 100 bp ~10 – 140 bp ~10 – 100 bp ~10 – 100 bp ~10 – 140 bp 45 ** Additional Software (SW) (PyroMark CpG SW) needed on ID and MD instruments Sample & Assay Technologies
  • 46. Pyrosequencing for DNA Methylation Analysis PyroMark CpG Assays – Release Information PyroMark CpG Assays PyroMark CpG Assays Pre-designed DNA-methylation assays Human Number of assays: over 30,000 Number of CpG Islands with assay: ~12,000 (~80%) Mouse Number of assays: over 30,000 Number of CpG Islands with assay: ~11,000 (<80%) 46 Sample & Assay Technologies
  • 47. Pyrosequencing Workflow PCR Can Use Any PCR Machine / PCR Reagents / Compatible with Q-PCR Amplify relevant region by PCR (60 - 1000 bp) Can Use Very Short PCR Products if Desired (i.e. Degraded DNA) One primer is biotinylated PCR primer Region of interest PCR primer biotinylated 47 Sample & Assay Technologies
  • 48. Pyrosequencing Workflow Sample preparation Assay Design PCR Sample prep Pyrosequencing Immobilize biotinylated PCR products onto streptavidin coated beads Separate strands by denaturation in NaOH Wash/neutralize the immobilized strand Anneal sequencing primer 48 Sample & Assay Technologies
  • 49. Pyrosequencing for DNA Methylation Analysis Analyzing a Pyrogram for DNA-methylation Sequence to be analyzed: • AGTTAC GAC m • After bisulfite conversion: AG T TAC GAC• and A G T T A C G A C • • AG TTATGAT • and A G T T A C G A T • Biotinylated PCR strand: 49 Sample & Assay Technologies
  • 50. Pyrosequencing for DNA Methylation Analysis Analyzing a Pyrogram for DNA-methylation Sequence to be analyzed: • AGTTAC GAC m • After bisulfite conversion: AG T TAC GAC• and A G T T A C G A C • • AG TTATGAT • and A G T T A C G A T • Biotinylated PCR strand: Analyzed sequence: CpG methylation level: 50 Sample & Assay Technologies
  • 51. Pyrosequencing for DNA Methylation Analysis A Range of Analysis Possibilities Any single CpG site A4: TAYGGTTTGTA 57% 200 150 100 50 0 E S A T G A T C G T G 5 Multiple consecutive CpG sites B 7 : Y G G T A T G T G G A T A T T T T Y G Y G T G G G T A T T T T T AYGGGGAT AT T T T GGT T AT YGT YGYGYGGAT AT T T T T AYGAGGAT AT T T YGGT YGYGYGGAT AT T T AT YGYGGGGAY 37% 35% 36% 33% 33% 32% 33% 30% 31% 38% 37% 29% 36% 30% 31% 34% 34% 2000 1500 1000 500 0 E S A TCGT A TGTGA TCGA T TC TG TCGTGTA TC TGA TC GGA TA T TGTCGA TCA GTC TGTCAGTCGA T A TC TGA TCGAGA TGA T TC TGTCAGTC TGT CGA TA TCGA TCAGTC GGTA TCAGT TCGA T 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100 105 110 115 120 One gene at a time Several genes in the same analysis (analyze up to 96 different assays in one run) Global methylation level Estimate the global methylation levels using repetitive elements 51 Sample & Assay Technologies
  • 52. Topics for Discussion Introduction DNA Methylation Overview Challenges & Solutions The EpiTect Methyl II PCR Array System Principle and Protocol Research Applications Pyrosequencing Summary 52 Sample & Assay Technologies
  • 53. DNA Methylation Analysis at QIAGEN Complete Solution from Sample Isolation through Data Analysis DNA Methylation is a promising biomarker and is important in regulating gene expression through several mechanisms DNA Methylation can be identified using simple restriction digests on a regional basis using the EpiTect Methyl II PCR Array System Complete system from DNA isolation through data analysis DNA Methylation can be identified on site-by-site basis using EpiTect pyrosequencing Simple, easy to use system with predesigned assays 53 Sample & Assay Technologies
  • 54. EpiTect Methyl II PCR System Pilot Project Starter Offer: 2 Free EpiTect Methyl II Signature Panels or 2 Free EpiTect Methyl II Assays With purchase of: DNA RE Kit SYBR Green MasterMix Call 1-888-503-3187 Use Code: FDK-MTFAS22 Outside US and Canada? Request demo QIAwebinars@QIAGEN.com 54 Sample & Assay Technologies
  • 55. EpiTect Methyl II Pilot Study 96 and 384 well qPCR Arrays-Human and Mouse Cancer Related Pathway-Focused Methyl qPCR Arrays Breast Cancer Apoptosis Epithelial to Mesenchymal Transition DNA Repair Gastric Cancer Inflammatory Response Liver Cancer T Cell Activation Lung Cancer Cytokine Production Prostate Cancer Tumor Suppressor Genes Colon Cancer Homeobox (HOX) Genes Leukemia & Lymphoma Polycomb (PcG) Genes Tumor Suppressor Genes Cell Cycle Melanoma Toll-Like Receptor Signaling Cancer miRNAs Stem Cell Transcription Factors TGF-Beta/BMP Signaling Wnt Signaling 55 Sample & Assay Technologies
  • 56. EpiTect Methyl qPCR System Questions, Comments, Concerns? US Applications Support 888-503-3187 support@sabiosciences.com ̣ Questions, Comments, Concerns? Global Applications Support SAB.EU@qiagen.com The EpiTect Methyl qPCR Arrays and Assays are intended for molecular biology applications. This product is not intended for diagnosis, prevention, or treatment of disease. 56 Sample & Assay Technologies